Ignyta Company

Ignyta is a scientifically driven biotechnology company catalyzing personalized medicine in autoimmune diseases. Their goals are to revolutionize the quality of biomarkers and tests available to rheumatologists and patients to help them make better informed, more individualized treatment decisions; and to identify truly novel autoimmune disease targets for biopharmaceutical companies to enable the development of precise therapies for patients worldwide.
Technology: P4 Medicine
Industry: Biotechnology, Health Care, Health Diagnostics
Headquarters: San Diego, California, United States
Founded Date: 2011-01-01
Employees Number: 101-250
Funding Status: M&A
Acquisitions Number: 1
Investors Number: 5
Total Funding: $375.5M
Estimated Revenue: Less than $1M
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership